Indivior Pharmaceuticals (INDV) Depreciation & Amortization (CF) (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Depreciation & Amortization (CF) of $2.0 million for Q1 2026, down 33.33% year-over-year from $3.0 million in Q1 2025, and little changed quarter-over-quarter from $2.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Depreciation & Amortization (CF) (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Depreciation & Amortization (CF) history runs 3 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 33.33% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $9.0 million (down 43.75% YoY), while the FY2025 annual figure was $10.0 million, down 37.5% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $2.0 million, roughly flat from $2.0 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $5.0 million in Q1 2024, with the low at $2.0 million in Q3 2025.
- The 3-year median for Depreciation & Amortization (CF) is $3.0 million (2025), against an average of $3.3 million.
- Peak annual rise in Depreciation & Amortization (CF) reached 25.0% in 2025, while the deepest fall reached 60.0% in 2025.
- Indivior Pharmaceuticals' Depreciation & Amortization (CF) stood at $5.0 million in 2024, then slumped by 60.0% to $2.0 million in 2025, then changed by 0.0% to $2.0 million in 2026.
- Business Quant data shows INDV's Depreciation & Amortization (CF) at $2.0 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.39 Bn | 4.16 Bn | 294.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Mar 31, 2024 | 5.00 Mn |